ATI RN Pharmacology 2023 IV | Nurselytic

Correct Answer: D

Rationale: The correct answer is D: Can you describe what your pain feels like? This question is crucial in determining the quality of pain, as it helps the nurse understand the characteristics of the pain (e.g., sharp, dull, burning). Understanding the quality of pain can provide valuable information for the nurse to identify potential causes and tailor appropriate pain management strategies.


Choice A is incorrect because pointing to the area of severe pain indicates location, not quality.
Choice B focuses on the timing of pain escalation, not quality.
Choice C assesses pain intensity on a numerical scale, not quality.

In summary, asking the adolescent to describe the pain sensation (choice
D) helps the nurse gain insights into the nature of the pain, which is essential for effective pain management.

Correct Answer: C

Rationale: The correct answer is C: Ataxia. Phenytoin is an antiepileptic medication that can cause ataxia, which is a condition characterized by loss of coordination and unsteady movements. Ataxia can be a sign of toxicity and requires immediate attention from the provider to adjust the dosage or consider alternative treatments.

A: Gingival hyperplasia is a common side effect of phenytoin but is not typically considered an urgent issue requiring immediate provider notification.

B: Drowsiness is a common side effect of phenytoin and may not necessarily indicate toxicity.

D: Hirsutism, or abnormal hair growth, is not typically associated with phenytoin use and is not a known adverse effect of the medication.


Therefore, the nurse should report ataxia to the provider as it may indicate a serious problem with the medication.

Correct Answer: D

Rationale: The correct answer is D: Propranolol. Albuterol is a beta-2 agonist used for asthma, which can interact with beta-blockers like propranolol, potentially causing severe bronchospasm and respiratory distress. The nurse should withhold the dose and notify the provider to avoid this dangerous interaction. Isosorbide mononitrate (
A) is a nitrate used for angina, not contraindicated with albuterol. Pantoprazole (
B) is a proton pump inhibitor for acid reflux, unrelated to albuterol. Montelukast (
C) is a leukotriene receptor antagonist for asthma, not contraindicated with albuterol.

Correct Answer: A

Rationale: The correct answer is A. Consulting the pharmacist to assess the compatibility of verapamil with newly ordered medications is crucial because verapamil is known to have significant drug interactions, especially with other medications that affect heart rhythms. Verapamil is a calcium channel blocker that can potentiate the effects of other antiarrhythmic drugs, leading to serious cardiac complications. By consulting the pharmacist, the nurse can prevent potential drug interactions and ensure the client's safety.

Option B is incorrect because reporting the client's refusal to take verapamil does not require pharmacist consultation but rather involves addressing the client's compliance issues directly. Option C is incorrect because requesting a change in the dosage of verapamil should be discussed with the prescriber, not the pharmacist. Option D is incorrect because verifying the frequency of administration of verapamil can be done by referring to the medication order without pharmacist consultation.

Correct Answer: A

Rationale: The correct answer is A: Hemorrhage. Alteplase is a thrombolytic medication that dissolves blood clots. One of its major adverse effects is the risk of causing hemorrhage due to its clot-dissolving action. Monitoring for signs of bleeding such as bruising, petechiae, hematemesis, or melena is crucial. Steatorrhea (
B) is unrelated to alteplase. Polycythemia (
C) is an increase in red blood cell count, not a known adverse effect of alteplase. Laryngospasm (
D) is a sudden spasm of the vocal cords, not associated with alteplase use.